Www.diahome.org DIA 6 th European Validation Workshop, Amsterdam, 2007. Building Change into Process David Bridges Director, eChange Solutions Limited.

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

ASYCUDA Overview … a summary of the objectives of ASYCUDA implementation projects and features of the software for the Customs computer system.
UNFCCC secretariat, programme Gyungae Ha, Programme Officer Ensuring sustainability in project assessment 7 th CDM Joint Coordination Workshop, Bonn, Germany,
Upgrading from Calibration Manager to Blue Mountain RAM
Upgrading the Oracle Applications: Going Beyond the Technical Upgrade Atlanta OAUG March 19, 1999 Robert Cooney.
Page 2 Agenda Page 3 History –Blue Print, 2000 –GIS Process 1.2, 2001 (training only) –GIS Process 2.0, (ITIL based - not implemented) –Supply/Demand.
Enhancing the CRO-Sponsor Collaboration to Ensure High Quality of Clinical Data May 17,2011 | Beijing, China Charles Yan, PhD Shanghai Clinical Research.
New Approaches to SAE Reconciliation for Paper and EDC Studies: A Collaborative Perspective Shannon Labout, CCDM Senior Consultant PSDM Meeting 22-May-2008.
Summer IAVA1 NATIONAL INFORMATION ASSURANCE TRAINING STANDARD FOR SYSTEM ADMINISTRATORS (SA) Minimum.
QlikView Using Qlikview for Student Reporting : A case study of the implementation of an innovative reporting tool in an HEI Mike Frost, Assistant Director.
The ICH E5 Question and Answer Document Status and Content Robert T. O’Neill, Ph.D. Director, Office of Biostatistics, CDER, FDA Presented at the 4th Kitasato-Harvard.
Selecting and Implementing an LMS for your Company Session Code #2411.
Pertemuan Matakuliah: A0214/Audit Sistem Informasi Tahun: 2007.
Tipologie di Audit e loro caratteristiche Riunione sottogruppo GCP-GIQAR 21 Marzo 2006 Francesca Bucchi.
COMP8130 and 4130Adrian Marshall 8130 and 4130 Test Management Adrian Marshall.
Laboratory Information Management Systems (LIMS) Lindy A. Brigham Div of Plant Pathology and Microbiology Department of Plant Sciences PLS 595D Regulatory.
Click to add text © 2010 IBM Corporation OpenPages Solution Overview Mark Dinning Principal Solutions Consultant.
Igal Kaptsan Research Director Applied Research, Bentley Systems Change Management.
000000_1 Confidential and proprietary information of Ingram Micro Inc. — Do not distribute or duplicate without Ingram Micro's express written permission.
11/2/991 CDER’s 21 CFR Part 11 Implementation Study Greg Brolund Associate Director, Office of Information Technology, CDER/FDA.
KEEP ‘Knowledge and Expertise in EU Programmes‘ A Capitalisation tool for EU-wide promotion of Territorial Cooperation.
Policy? Guidance? Standard Operating Procedure? Tips on how to achieve compliance with minimum red tape Carolyn Bargoot, Associate Director Post-Award.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Welcome ISO9001:2000 Foundation Workshop.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
1/18/2005Module 41 How the NCSX Project Does Business Work Planning & Design Review Processes.
Pharmacovigilance Programme of India
FDA Docket No. 2004N-0133 Themes for Renewal of 21 CFR Part 11 Rule & Guidance by Dr. Teri Stokes, GXP International
AOIT Introduction to Programming Unit 4, Lesson 11 Documenting Bugs and Fixes Copyright © 2009–2012 National Academy Foundation. All rights reserved.
1 ISA&D7‏/8‏/ ISA&D7‏/8‏/2013 Systems Development Life Cycle Phases and Activities in the SDLC Variations of the SDLC models.
PRODUCT TRANSFER.
Encouraging adaptive designs in NiHR funded clinical trials Professor Sallie Lamb Chair, CET Board.
Relationships July 9, Producers and Consumers SERI - Relationships Session 1.
SIPLAS RO is a full service contract research organization CRO, offering nanotechnology, biopharmaceutical and medical device companies comprehensive.
PwC 21 CFR Part 11 – A Risk Management Perspective Patrick D. Roche 07 March 2003, Washington D.C.
Component 2: The Culture of Health Care Unit 9: Sociotechnical Aspects: Clinicians and Technology Lecture 1 This material was developed by Oregon Health.
1 7 th CACR Information Workshop Vulnerabilities of Multi- Application Systems April 25, 2001 MAXIMUS.
ໂດຍ: ວິສອນ ໄຊສົງຄາມ ກົມຄຸ້ມຄອງສະຖາບັນການເງິນ, ທະນາຄານແຫ່ງ ສປປ ລາວ
David Bridges eChange Solutions Limited Drug Development Projects Business Change Projects.
Planning for security Microsoft View
How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.
Clinical Application. The Problem Clinical Systems are extremely complex IT configures and deploys best practices (best guesses) about what users want.
Connecting the Dots A Practical Approach to Integrating Compliance, Risk and Quality Jody Ann Noon RN, JD Partner Health Care Regulatory Practice.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
U. S. Department of Transportation Pipeline and Hazardous Materials Safety Administration
Tracking national portfolios and assessing results Sub-regional Workshop for GEF Focal Points in West and Central Africa June 2008, Douala, Cameroon.
Stand Up Comedy Project/Product Management
11 i Upgrade: Is an Assessment Useful for Your Company? By: Bernard Doyle, Applications Software Technology Corp. Marie Klein, Information Resources Inc.
ANALYSIS PHASE OF BUSINESS SYSTEM DEVELOPMENT METHODOLOGY.
Community surgery : staying out of trouble. Miss Nicola Lennard : 12 June 2015:
Presentation: SAS Drug Development Project Background - GAP analysis:
Aircraft Fleet Management Solutions
1 From Regulatory Intelligence to Compliance Debbie Henderson Head, Global Regulatory Policy EU Ring May 13, 2014.
Business Considerations in eTMF Implementation Karen Roy Phlexglobal Ltd.
18 January 2006 Copenhagen ERO - TISPAN WG4 meeting
Introduction Review and proper registration of Human Gene Transfer protocols is very complex. A protocol goes through rigorous review by multiple Committees.
Managing Complexity Through Innovation
EffiChem Presentation
Practical Implications Laura Lovato, Biostatistician
The Information Professional’s Role in Product Safety
1. Structure and training objectives for this course & key references
Pharmaceutical Quality in the 21st Century
Claire McKinley, PMP, CCRP
An FDA Statistician’s Perspective on Standardized Data Sets
Code of Ethics for CDM Professionals
Code of Ethics for CDM Professionals
Module 1.1 Overview of Master Facility Lists in Nigeria
Presentation transcript:

DIA 6 th European Validation Workshop, Amsterdam, Building Change into Process David Bridges Director, eChange Solutions Limited eChange Solutions Limited

Introduction Impact of change on validated systems How to manage change Contrast with processes and recourses used in new system introduction / major upgrades. Drawing examples from the European Biometrics Department of an (un-named) global research based pharma. Company.

Biometrics systems Query Management RDE CDMS Reporting & Statistical Analysis Submission Compilation & Publishing Work Tracking Resource Management Image Management

Biometrics systems Query Management RDE CDMS Reporting & Statistical Analysis Submission Compilation & Publishing Work Tracking Resource Management Image Management

Biometrics systems Query Management RDE CDMS Reporting & Statistical Analysis Submission Compilation & Publishing Work Tracking. Resource Management Image Management

Data Extraction Major System Change Query Management RDE Image Management CDMS Reporting & Statistical Analysis Data transfer Data entry OCR Query Generation Major change is usually focuses on a single system and it’s interfaces

Scope : Requirement Design Development Testing Training Release Support planning System introduction / major upgrade CDMS Validation

System introduction / major upgrade CDMS Usually : Organized as a project High level sponsorship (business & technical) High visibility “Business” involvement Best practice in –Change management –Configuration management –Risk management May also : Form part of a change programme Benefit from project office

Data Extraction Validation of system Query Management RDE Image Management CDMS Reporting & Statistical Analysis Data transfer Data entry OCR Query Generation Validation focuses on a single system and it’s interfaces

Validation paradigm Investigator FDA A chain of validated systems : Each of which has been validated to demonstrate its fitness for purpose. That together ensure the authenticity, integrity, confidentiality and signer non-repudiation of records from the investigator to regulatory authority.

So What is the problem ! These system do not exist in a static environment. In fact, the environment is less “under control” that the systems ! Changes to : –Organization structure –Staff –Processes (SOPs) –Use of system –IT infrastructure –System functionality (minor changes, bug fixes) All have potential to compromise the effective operation of the system.

Scale of change : Biometrics At any one time involved with approx. 20 drugs. 4 in phase III and a further 4 post primary submission. Estimated duration of involvement with drug that is approved is 15 years Biometrics involved with drugs in phase 1-3 & also drugs where primary submission complete but further submission (country, indication) required. IPost SubmissionIIIII

Think about it ! What changes have occurred in your organization in the last 15 years ? –Organization structure –Staff –Processes (SOPs) –Use of system –IT infrastructure

RDE3 Image Management2 CDMS3 Query Management4 Report & statistical analysis2 Submission Compilation and Publishing1 Work Tracking>4 Resource Management>5 System Duplication Systems change but data migration is risky and expensive This leads to system duplication

Managing change Management of change to : Organization structure Staff Processes (SOPs) All require similar processes and resources Change management Configuration management Risk management Use of system IT infrastructure System functionality (minor/bugs) Change control boards Designated staff Inventories Decision makers

Managing change Management of change to : Organization structure Staff Processes (SOPs) All result in similar outcomes Document and proceed Undertake partial risk-based validation Undertake full validation Use of system IT infrastructure System functionality (minor/bugs)

Analysis of validation events Over a three year period there were 41 changes to systems or processes requiring full or partial re-validation impacting the Clinical Data Management System (CDMS). Half related to upgrades of the CDMS system itself, while the remainder related to auxiliary systems and infrastructure products such as the database, SAS and the operating system.

Analysis of validation events Of the 41 events 11 were infrastructure driven : –4 database –9 Server –Of these 2 were driven by infrastructure change required by another validated system 2 were database migration projects 12 were releases of new functionality (including bugs) 16 were bug-fix releases Significant number of infrastructure and process deemed not to require re-validation by CCBs.

Final points Can not achieve compliance by focusing on change management of the system alone. Most organizations have multiple CCB’s (& they don’t talk to each other !). One man’s focus of responsibility is another man’s risk.

Practical advice Determine what the sources of change are and how they are controlled Encourage best practice within each domain Encourage communication and mutual support Put in place safety net (Support Plan)

Questions ? Many Thanks Slides can be downloaded from : from Monday Or leave me a business card and I will them to you.